• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.57% Nasdaq Up0.40%

    Intercept Pharmaceuticals, Inc. (ICPT)

    -NasdaqGS
    238.27 Down 3.11(1.29%) 12:21PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 1,445   445   445   445  
    Cost of Revenue -   -   -   -  
    Gross Profit 1,445   445   445   445  
    Operating Expenses
    Research Development27,966  23,718  27,381  14,919  
    Selling General and Administrative13,138  11,859  9,136  7,955  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (39,658) (35,132) (36,072) (22,429)
    Income from Continuing Operations
    Total Other Income/Expenses Net272  308  228  55,899  
    Earnings Before Interest And Taxes(39,386)(34,824)(35,843)33,470  
    Interest Expense -   -   -   -  
    Income Before Tax(39,386)(34,824)(35,843)33,470  
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(39,386)(34,824)(35,843)33,470  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (39,386) (34,824) (35,843) 33,470  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (39,386) (34,824) (35,843) 33,470  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.